HOME >> BIOLOGY >> NEWS
Latest knowledge on plant cell-wall biology in new book

ITHACA, N.Y. -- The wall of a plant cell is no longer just a biological bulwark. It is a critical component in science.

To update other biologists with fresh information about plant cell walls, Jocelyn Rose, a Cornell University assistant professor of plant biology, has edited a new book, The Plant Cell Wall , published by Blackwell Publishing. "This book is especially appropriate given the recent completion of the first plant-genome sequencing projects and our entry into the 'post-genomic' era," said Rose, who joined the Cornell faculty as part of the university's Genomics Initiative. "Such breakthroughs have given an exciting glimpse into the substantial size and diversity of the families of genes encoding cell wall-related proteins."

In his own laboratory, Rose and his colleagues focus on the structure, function and metabolism of plant cell walls and also their pivotal role in fending off pathogens. "Cell walls represent a major frontier in plant biotechnology, reflected in their importance in a broad range of plant-derived products, contributing to the food, fiber and material science industries," he said. "In addition to their critical importance for plants, they influence so many aspects of our daily life, such as structural materials in paper and wood, fuel, clothing in the form of cotton and, of course, nutrition -- that all important dietary fiber."

In the last few years, biological science has developed fresh analytical tools used in molecular biology, biochemistry, spectroscopy, microscopy, immunology, genomics and proteomics. They are used to investigate plant cell-wall structure and function. The high resolution of these tools was impossible to imagine a few years ago, said Rose. "But the emergence of plant-cell research has resulted in a growing awareness of the critical role of plant cell walls in a broad range of developmental events, adding strength and diversity to cell wall-related scientific research." An overview of
'"/>

Contact: Blaine P. Friedlander Jr.
bpf2@cornell.edu
607-255-3290
Cornell University News Service
4-Dec-2003


Page: 1 2

Related biology news :

1. Latest findings on PCBs to be subject of June workshop at Illinois
2. Latest research in gene therapy presented at 6th Annual ASGT meeting
3. Latest farm product: Meadowbirds
4. Worlds Leading Echinacea Researchers To Examine Latest Scientific Findings On "Natures Gentle Antibiotic"
5. Renowned Prostate Cancer Experts Present Latest Findings At UCSF Cancer Center Symposium
6. Bees: Latest Weapon In Cancer Fight
7. Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats
8. Montana State University Scientist Contributes To Latest Dinosaur Discovery
9. Cystic Fibrosis Conference Will Showcase Latest From Clinical Care To Basic Science
10. Bug Experts Latest Books Feature Simple Language, Vivid Photos
11. 3,500 Earth And Space Scientists To Report Latest Findings At Boston Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Latest knowledge plant cell wall biology new book

(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, a ... Internet of Things (IoT), today announced the appointment of ... operating officer. Previously a strategic advisor to the firm, ... operations. Mr. Traynor is based out of the C-Labs ... reports to Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... -- The Secure Identity & Biometrics Association (SIBA) and ... formation of The Airport Entry and Exit Working ... Biometric Entry and Exit Solutions Framework for Airports ... BORDERPOL, the international non-profit organization that works directly ... border security, traveler and migration systems. ...
(Date:11/18/2014)... 2014 The Parenteral Drug Association (PDA) today confirmed ... speak and at least seven more will participate in the ... Shoreham Hotel in Washington D.C. , Dec. ... significant support from the regulatory agencies in the ... in our effort to help advance the use of metrics ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 ... today that it has entered into a technology ... Company (ADM) to apply DNA2.0’s proprietary protein engineering ... engineering process. , “We are extremely excited that ... engineering platform. This proprietary bioengineering technology has ...
(Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
(Date:12/15/2014)... PETACH TIKVAH, Israel , Dec. 15, ... BCLI ), a leading developer of adult stem cell ... Brainstorm Cell Therapeutics Ltd. was awarded a grant of ... Office of the Chief Scientist (OCS).  This is the ... grant support from the Office of the Chief Scientist, ...
(Date:12/15/2014)... , Dec. 15, 2014  Ascendis Pharma ... TransCon technology to address significant unmet medical needs, ... ongoing Phase 2 pediatric study to evaluate once-weekly ... deficiency, or GHD.  This interim analysis consists of ... total enrollment in the study, completing all six ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4
Cached News: